The Influence of Bariatric Surgery on Matrix Metalloproteinase Plasma Levels in Patients with Type 2 Diabetes Mellitus

• Published in: Biomolecules (Basel, Switzerland) Switzerland), 2024-12, Vol.14 (12), p.1633
• Main Authors: Gentile, João Kleber de Almeida, Migliore, Renato, Waisberg, Jaques, Ribeiro Junior, Marcelo Augusto Fontenelle
• Format: Article
• Language: English
• Subjects: Adipose tissue; Adipose tissues; Adult; Antibodies; Bariatric Surgery; Biomarkers - blood; Body fat; Body mass index; Body weight loss; Cardiovascular disease; Care and treatment; Comorbidity; Diabetes; diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - surgery; Enzymes; Extracellular matrix; Female; gastric bypass; Gastrointestinal surgery; gastroplasty; Gelatinase A; Gelatinase B; Humans; Insulin resistance; Male; Matrix metalloproteinase; Matrix Metalloproteinase 2 - blood; Matrix Metalloproteinase 9 - blood; Matrix Metalloproteinase 9 - metabolism; matrix metalloproteinases; Medical research; Medicine, Experimental; Metabolic syndrome; Metabolism; Metalloproteinase; Middle Aged; morbid obesity; Obesity; Obesity, Morbid - blood; Obesity, Morbid - metabolism; Obesity, Morbid - surgery; Oxidative stress; Patients; Plasma; Plasma levels; Prospective Studies; Surgery; Type 2 diabetes; Weight control; Weight Loss; Womens health
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom14121633

Bariatric surgery is a safe and effective procedure for treating obesity and metabolic conditions such as type 2 (T2DM). Remodeling of the extracellular matrix (ECM) supports adipose tissue expansion and its metabolic activity, where matrix metalloproteinases (MMPs) play a key role in ECM regulation. The MMPs, particularly MMP-2 and MMP-9, are elevated in patients with morbid obesity, metabolic syndrome, and T2DM. To evaluate the effect of weight loss in bariatric surgery patients using oxidative stress markers and to compare MMP levels in patients undergoing bariatric surgery. This was a prospective, controlled study including 45 morbidly obese patients with T2DM (BMI > 35 kg/m ) who underwent RYGB (n = 24) or VG (n = 21). Weight loss was assessed through anthropometric measurements (weight, height, BMI). MMP-2 and MMP-9 levels were measured preoperatively and at 3 and 12 months postoperatively. Significant and sustained weight loss was observed after surgery in both groups, with reductions in BMI. MMP-2 and MMP-9 levels decreased significantly after one year of follow-up. Bariatric surgery is an effective long-term intervention for weight loss and associated comorbidities, including T2DM. MMP-2 and MMP-9 proved to be effective markers of extracellular matrix remodeling, with significant reductions following surgery.